Blog

- FEMTECH

Nasal mask support improves breathing in preterm babies in clinical trial

Using a nasal mask instead of a traditional face mask to support very premature babies at birth can significantly reduce the need for rescue breathing and escalation of care, a world-first trial led by researchers at Monash University’s School of Clinical Sciences at Monash Health, in collaboration with Hudson Institute of Medical Research and Monash Children’s Hospital (Monash Health), has shown.

Read More »

AbbVie receives marketing authorization from MHRA

AbbVie has announced that it has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ELAHERE (mirvetuximab soravtansine) as monotherapy for the treatment of eligible adult patients with folate receptor-alpha (FRα) positive, platinum-resistant high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic treatment regimens.

Read More »